Obesity-induced CYP2E1 activity in children
Br J Clin Pharmacol
.
2019 Feb;85(2):458-459.
doi: 10.1111/bcp.13813.
Epub 2018 Dec 9.
Authors
Christina Gade
1
,
Kim Dalhoff
1
,
Tonny Petersen
1
,
Troels Riis
1
,
Camilla Schmeltz
2
,
Elizaveta Chabanova
3
,
Hanne Rolighed Christensen
1
,
Gerd Mikus
4
,
Juergen Burhenne
4
,
Jens Christian Holm
2
5
,
Helle Holst
1
Affiliations
1
Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark.
2
The Children's Obesity Clinic, Department of Paediatrics, Copenhagen University Hospital Holbaek, Denmark.
3
Department of Radiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
4
Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Germany.
5
Novo Nordisk Foundation Centre for Basic Metabolic Research, Denmark.
PMID:
30537026
PMCID:
PMC6339961
DOI:
10.1111/bcp.13813
No abstract available
Publication types
Letter
Comment
MeSH terms
Child
Chlorzoxazone*
Cytochrome P-450 CYP2E1*
Humans
Liver
Obesity
Substances
Cytochrome P-450 CYP2E1
Chlorzoxazone